Log In
BCIQ
Print this Print this
 

intranasal diazepam (NRL-1)

  Manage Alerts
Collapse Summary General Information
Company Neurelis Inc.
DescriptionIntranasal formulation of diazepam
Molecular Target GABA A receptor
Mechanism of ActionGABA A receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationEpilepsy
Indication DetailsTreat acute repetitive seizures in pediatric, adolescent, and adult epilepsy patients; Treat breakthrough seizures associated with epilepsy
Regulatory Designation U.S. - Orphan Drug (Treat acute repetitive seizures in pediatric, adolescent, and adult epilepsy patients)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

06/10/2013

Undisclosed

0

Undisclosed

Get a free BioCentury trial today